Tailored hydration for the prevention of post-ERCP(endoscopic retrograde cholangiopancreatography) pancreatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003196

Enrollment

350

Registered

2018-09-20

Start date

2018-11-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Different hydration rate of lactated ringer&#39

s solution during and after ERCP(endoscopic retrograde cholangiopacreatography) 1) Tailored standard hydration : hydration rate of 1.5mL/kg during and after ERCP 2) Tailored aggressive hydration : Bol

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients older than 20 years undergoing ERCP for the 1st time

Exclusion criteria

Exclusion criteria: Age below 20 or above 80 years Underlying severe psychiatric illness Cardiac insufficiency (>New York Heart Association Class II heart failure) Renal insufficiency (eGFR <30mililiter/min/1.73m2) Respiratory insufficiency (defined as oxygen saturation < 90%) Poorly controlled blood sugar Ongoing hypotension including those with sepsis Ongoing acute pancreatitis Underlying disease of chronic pancreatitis Clinical signs of hypervolemia Hyponatremia (Na+ levels < 130 miliequivalent (mEq)/L)) Hypernatremia (Na+ levels > 150mEq/L) Hyperkalemia (5.1 mEq/dL) Metabolic alkalosis Past history of endoscopic sphincterectomy or endoscopic papillary balloon dilatation

Design outcomes

Primary

Measure	Time frame
Development of post-ERCP pancreatitis	—

Secondary

Measure	Time frame
Clinical volume overload;Hyperamylasemia;Increased abdominal pain;Hospital stay	—

Countries

Korea, Republic of

Contacts

Public ContactEun ae Cho

Chonnam National University Hospital

cea202@hanmail.net+82-62-220-6216

Outcome results